ACM
EW icon

Aster Capital Management’s Edwards Lifesciences EW Stock Holding History

Aster Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
+1,482
New +$122K 0.04% 317
2025
Q4 		– Sell
-7,263
Closed -$565K – 1186
2025
Q3 		$565K Buy
7,263
+4,805
+195% +$375K 0.29% 90
2025
Q2 		$192K Buy
+2,458
New +$183K 0.04% 386
2025
Q1 		– Sell
-8,642
Closed -$640K – 1377
2024
Q4 		$640K Buy
8,642
+7,699
+816% +$539K 0.24% 110
2024
Q3 		$62.2K Buy
+943
New +$68.5K 0.01% 453

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Aster Capital Management's EW Position: Q1 2026 in Review

Aster Capital Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 1,482 shares worth $107K. The stake represents 0.04% of the portfolio and ranks #317 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in EW as recently as Q3 2025.

Aster Capital Management first reported a position in EW in Q3 2024 and has held it in 5 quarters since. The position peaked at $640K in Q4 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Aster Capital Management held 1,482 shares of Edwards Lifesciences worth $107K as of Q1 2026.
  • Edwards Lifesciences was a new Aster Capital Management position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Aster Capital Management's portfolio in Q1 2026, its #317 holding.
  • Aster Capital Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Edwards Lifesciences position peaked at $640K in Q4 2024.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.